Atrial Cardiopathy and Likely Pathogenic Patent Foramen Ovale in Embolic Stroke of Undetermined Source

Ioannis A Leventis1, Dimitrios Sagris1, Davide Strambo2

  • 1Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.

Thrombosis and Haemostasis
|September 3, 2020
PubMed

Insights

In patients with embolic stroke of undetermined source (ESUS), atrial cardiopathy and likely pathogenic patent foramen ovale (PFO) are inversely related. This suggests these conditions may not frequently coexist as causes of stroke.

Area of Science:

  • Cardiology
  • Neurology
  • Stroke Research

Background:

  • Atrial cardiopathy and patent foramen ovale (PFO) are potential causes of embolic stroke of undetermined source (ESUS).
  • The co-occurrence and relationship between these two embolic sources in ESUS patients are not well understood.

Purpose of the Study:

  • To investigate the relationship between atrial cardiopathy and likely pathogenic PFO in patients diagnosed with ESUS.

Main Methods:

  • Atrial cardiopathy was defined by electrocardiogram findings (left atrial enlargement, PR prolongation, supraventricular extrasystoles).
  • PFO presence was assessed using echocardiography; likely pathogenic PFO was determined by a Risk of Paradoxical Embolism score of 7-10.
  • The study analyzed 367 ESUS patients with data on both conditions.

Main Results:

  • Likely pathogenic PFO was found in 16.9% and atrial cardiopathy in 33.2% of ESUS patients.
  • Only 1.1% of patients had both conditions.
  • Atrial cardiopathy was less prevalent in patients with likely pathogenic PFO (6.5%) compared to those without (40.6%).
  • Likely pathogenic PFO was less prevalent in patients with atrial cardiopathy (3.3%) compared to those without (23.7%).

Conclusions:

  • The presence of atrial cardiopathy is inversely associated with the presence of likely pathogenic PFO in ESUS patients.
  • These findings suggest that atrial cardiopathy and pathogenic PFO may be alternative rather than concurrent embolic mechanisms in ESUS.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
313
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
364
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
239
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
250
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
352
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
466